MomL inhibits bacterial antibiotic resistance through the starvation stringent response pathway.

Antibiotic resistance in gram-negative pathogens has become one of the most serious global public health threats. The role of the -acyl homoserine lactone (AHL)-mediated signaling pathway, which is widespread in gram-negative bacteria, in the bacterial resistance process should be studied in depth. Here, we report a degrading enzyme of AHLs, MomL, that inhibits the antibiotic resistance of through a novel mechanism. The MomL-mediated reactivation of kanamycin is highly associated with the -mediated starvation stringent response. The degradation of AHLs by MomL results in the inability of LasR to activate , which, in turn, stops the activation of downstream . Further results show that directly regulates the type VI secretion system H2-T6SS. Under MomL treatment, inactivated RpoS fails to regulate H2-T6SS; therefore, the expression of effector phospholipase A is reduced, and the adaptability of bacteria to antibiotics is weakened. MomL in combination with kanamycin is effective against a wide range of gram-negative pathogenic bacteria. Therefore, this study reports a MomL-antibiotic treatment strategy on antibiotic-resistant bacteria and reveals its mechanism of action.